Evidence map›Paper›PMID 39441449›Full record

ArticleDiscover oncology2024

Overexpression of a disintegrin and metalloproteinase 9 (ADAM9) in relation to poor prognosis of patients with oral squamous cell carcinoma.

Shuangjiang Wu, Lang Cheng, Tao Luo, Anupong Makeudom, Lei Wang, Suttichai Krisanaprakornkit

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuangjiang Wu *Department of Oral and Maxillofacial Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Lang Cheng *School of Stomatology, Southwest Medical University, Luzhou, China.
Tao LuoDepartment of Pathology, The Fifth Hospital of Deyang, Deyang, China.
Anupong MakeudomSchool of Dentistry, Mae Fah Luang University Medical Center, Mae Fah Luang University, 365 Moo 12, Nang Lae Subdistrict, Mueang Chiang Rai District, Chiang Rai, 57100, Thailand.
Lei WangDepartment of Oral and Maxillofacial Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Suttichai KrisanaprakornkitSchool of Dentistry, Mae Fah Luang University Medical Center, Mae Fah Luang University, 365 Moo 12, Nang Lae Subdistrict, Mueang Chiang Rai District, Chiang Rai, 57100, Thailand. suttichai.kris@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the expressions of ADAM9, CDCP1 and t-PA in OSCC and their impacts on patient prognosis. Previous research has demonstrated the overexpression of ADAM9 and activation of plasminogen activator in OSCC, but CDCP1's role remains unexplored. While these biomolecules are known to contribute to lung cancer metastasis, their concurrent expressions in OSCC have not been thoroughly examined. Our aim is to assess the expressions of ADAM9, CDCP1, and t-PA in OSCC specimens, compare them with normal oral tissues, and explore their correlation with OSCC's clinicopathological features and patient survival outcomes.

Indexed as

A disintegrin and metalloproteinase 9CUB domain-containing protein 1Oral squamous cell carcinomaOverexpressionTissue-type plasminogen activato

Identifiers

PMID39441449
PMCPMC11499557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.